Rob Maloney: A Bruise that Did Not Go Away…
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”A bruise that didn’t go away.
A teenager playing baseball took a hard shot to the thigh.
There was a bruise and some swelling. Nothing unusual.
Except it didn’t go away.
A week passed. Then two. Still swollen and painful.
Doctor after doctor. Then the words no parent expects to hear: Hemophilia.
Years of their son’s life instantly reframed.
How did we miss this?
What if he’d hit his head instead?
What happens next time?
And for his mom, a deeper sentence she could barely get out:
“I didn’t know I was a carrier.”
If you’ve walked near this world, you know the emotional terrain.
Fear and guilt. Confusion and overwhelmed.
This is the part of healthcare you’ll never see on an organizational chart or in a claim file.
It’s the human weight behind every rare diagnosis.
When that family eventually landed with Hemophilia of Georgia, everything shifted.
Our nurse and social worker didn’t start with paperwork, but with presence.
• Home infusion training
• What to do before the next dental procedure or surgery
• Insurance navigation
• Education on the disease
• Scholarships and long-term support
• Space for a mom to ask every question she’d been holding in
This wasn’t a quick discharge and a follow-up call.
It was wraparound care. Clinical, emotional, and practical.
That moment taught me something I haven’t forgotten.
A rare diagnosis requires a rare kind of support.
And when it happens, families shouldn’t feel like they’re walking through it alone.”
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk